Review: taking Altace and Losartan potassium together


Summary

Drug interactions are reported among people who take Altace and Losartan potassium together. This review analyzes the effectiveness and drug interactions between Altace and Losartan potassium. It is created by eHealthMe based on reports of 645 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Altace and Losartan potassium >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Altace

Altace has active ingredients of ramipril. It is often used in high blood pressure. (latest outcomes from Altace 17,748 users)

Losartan Potassium

Losartan potassium has active ingredients of losartan potassium. It is often used in high blood pressure. (latest outcomes from Losartan potassium 12,880 users)

On Aug, 24, 2016

645 people who take Altace, Losartan Potassium are studied.


Number of reports submitted per year:

Altace and Losartan potassium drug interactions.

Drug effectiveness over time:

Altace:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 2 people)
  • not specified: 0.0% - (0 of 0 people)
Losartan Potassium:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 2 people)
  • 10+ years: 0.0% - (0 of 2 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Altace:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 3 people)
Losartan Potassium:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 3 people)

Drug effectiveness by age:

Altace:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 3 people)
Losartan Potassium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 3 people)

Most common drug interactions over time *:

< 1 month:
  • vision blurred
  • visual impairment
  • blood pressure increased
  • drug hypersensitivity
  • nausea
  • dizziness
  • hypoaesthesia
  • vertigo
  • hepatic encephalopathy
  • drug intolerance
1 - 6 months:
  • crying
  • feelings of worthlessness
  • suicidal ideation
  • feeling abnormal
  • atrial fibrillation
  • cardiac valve disease
  • pulmonary oedema
  • dry eye
  • eye pain
  • hepatic encephalopathy
6 - 12 months:
  • metastases to bladder
  • prostate cancer metastatic
  • anorexia
  • asthenia
  • creatinine renal clearance decreased
  • diplopia
  • dizziness
  • general physical health deterioration
  • impaired driving ability
  • malaise
1 - 2 years:
  • aphasia
  • hemiparesis
  • ischaemic stroke
  • glossitis
  • urinary tract infection
  • ageusia
  • blood glucagon abnormal
  • epistaxis
  • abdominal pain
  • abdominal sepsis
2 - 5 years:
  • abdominal pain upper
  • blood amylase increased
  • breast cancer
  • coronary artery disease
  • decreased appetite
  • essential hypertension
  • glaucoma
  • lipase increased
  • myocardial infarction
  • overdose
5 - 10 years:
  • aphasia
  • eczema
  • hemiparesis
  • ischaemic stroke
  • xerosis
  • urinary tract infection
  • blood glucagon abnormal
  • blood immunoglobulin e increased
  • depression
  • dry eye
10+ years:
  • congenital cystic kidney disease
  • diabetic eye disease
  • diabetic foot
  • diabetic neuropathy
  • fifth disease
  • heat stroke
  • rheumatic heart disease
  • back pain
  • depression
  • exhaustion, fatigue, lethargy, tiredness, weariness
not specified:
  • fatigue
  • dyspnoea
  • blood pressure increased
  • cough
  • dizziness
  • gait disturbance
  • nausea
  • cardiac failure congestive
  • oedema peripheral
  • pain

Most common drug interactions by gender *:

female:
  • visual impairment
  • nausea
  • vision blurred
  • drug hypersensitivity
  • blood pressure increased
  • dizziness
  • hypoaesthesia
  • vertigo
  • oedema peripheral
  • depression
male:
  • dyspnoea
  • fatigue
  • myalgia
  • gait disturbance
  • cough
  • confusional state
  • pain
  • myocardial infarction
  • cardiac failure congestive
  • blood pressure increased

Most common drug interactions by age *:

0-1:
  • pulmonary embolism
  • proteinuria
  • haemolytic uraemic syndrome
  • cardio-respiratory arrest
  • glomerular filtration rate decreased
  • grand mal convulsion
  • herpes zoster
  • hypertension
  • infection
  • nephrotic syndrome
2-9:
  • anaemia
  • blood creatinine increased
  • drug ineffective
  • hyperkalaemia
  • proteinuria
  • renal impairment
10-19:
  • pulmonary hypertension
  • cyanosis
  • arteriovenous fistula
  • blood pressure decreased
  • cardiac failure acute
  • confusional state
  • hypoxia
  • loss of consciousness
  • oliguria
  • renal failure acute
20-29:
  • antiphospholipid syndrome
  • cardiovascular disorder
  • erosive oesophagitis
  • injection site pain
  • myocardial infarction
  • sudden death
  • arrhythmia
  • breast tenderness
  • menstruation delayed
  • ventricular arrhythmia
30-39:
  • myocardial ischaemia
  • hypoglycaemia
  • shock hypoglycaemic
  • blood cholesterol increased
  • diabetes mellitus inadequate control
  • hyperglycaemia
  • hypertension
  • intervertebral disc degeneration
  • type 2 diabetes mellitus
  • cytomegalovirus infection
40-49:
  • hepatic encephalopathy
  • anxiety
  • suicidal ideation
  • depression
  • crying
  • feelings of worthlessness
  • feeling abnormal
  • eye swelling
  • loss of consciousness
  • dyspnoea
50-59:
  • osteoarthritis
  • cough
  • fatigue
  • confusional state
  • dyspnoea
  • feeling abnormal
  • myalgia
  • blood pressure increased
  • dysstasia
  • depressed mood
60+:
  • nausea
  • dizziness
  • visual impairment
  • vision blurred
  • blood pressure increased
  • drug hypersensitivity
  • hypoaesthesia
  • vertigo
  • gait disturbance
  • oedema peripheral

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Altace and Losartan potassium?

Can you answer these questions?

More questions for: Altace, Losartan potassium

You may be interested in these reviews

More reviews for: Altace, Losartan potassium

On eHealthMe, Altace (ramipril) is often used to treat high blood pressure. Losartan potassium (losartan potassium) is often used to treat high blood pressure. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.